Back to top

Evaxion to Unveil Three-Year EVX-01 Melanoma Data at ESMO 2026

Evaxion Biotech ( ($EVAX) ) has shared an update. On July 17, 2026, Evaxion announced plans to present three-year clinical efficacy data from its p...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Evaxion A/S - Sponsored ADR (EVAX)